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Abstract
Protein synthesis is a fundamental cell process and ribosomes - particularly through the ribosomal RNA that display
ribozyme activity - are the main effectors of this process. Ribosome biogenesis is a very complex process involving
transcriptional as well as many post-transcriptional steps to produce functional ribosomes. It is now well demonstrated
that ribosome production is enhanced in cancer cells and that ribosome biogenesis plays a crucial role in tumor
progression. However, at present there is an important lack of data to determine whether the entire process of ribosome
biogenesis and ribosome assembly is modified during tumor progression and what could be the potential impact on the
dysregulation of translational control that is observed in cancer cells. In breast cancer cells displaying enhanced aggressivity,
both in vitro and in vivo, we have analyzed the major steps of ribosome biogenesis and the translational capacity of the
resulting ribosome. We show that increased tumorigenicity was associated with modifications of nucleolar morphology and
profound quantitative and qualitative alterations in ribosomal biogenesis and function. Specifically cells with enhanced
tumor aggressivity displayed increased synthesis of 45S pre-rRNA, with activation of an alternative preRNA synthetic
pathway containing a 43S precursor and enhanced post-transcriptional methylation of specifc sites located in the 28S rRNA.
While the global translational activity was not modified, IRES-initiated translation, notably that of p53 mRNA, was less
efficient and the control of translational fidelity was importantly reduced in cells with increased aggressivity. These results
suggest that acquisition of enhanced tumor aggressivity can be associated with profound qualitative alterations in
ribosomal control, leading to reduced quality control of translation in cancer cells
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Introduction
Nucleoli were among the first structures of eucaryotic cell nuclei
to have been identified and functionally characterized. Nucleoli are
now recognized as multifunctional domains containing some 700
different types of proteins involved in several fundamental processes
of cell life such as ribosome biogenesis, RNA maturation, cell cycle
and apoptosis regulation [1–3]. It has been known for many years
that nucleoli undergo to profound morphological alterations in
cancer cells. Hypertrophy of the nucleolus, visualized by analysis of
silver-stained nucleolar organizer regions (AgNORs) is one of the
most distinctive cytological features of cancer cells [4,5]. AgNOR
analysis is even considered as a ‘‘gold standard’’ when retrospective
studies on archival, formalin-fixed, and paraffin-embedded material
are performed [6]. AgNOR analysis is an independent prognostic
factor for almost every cancer analyzed so far and is regarded as one
of the major and independent prognostic factor for clinical decision
making in colorectal adenocarcinoma as well as invasive prostate
cancer [5,6].
Ribosome biogenesis takes place mainly within nucleoli and is
characterized by the ultra-structural organization in three main
compartments, the fibrillar centers (FC) containing rDNA gene
clusters, the dense fibrillar centers (DFC) where rDNA gene
transcription and post-transcriptional processing occurs and the
granular component (GC) in which final maturation and assembly
takes place [7]. Ribosomal biogenesis involves probably more than
170 accessory factors [2] and requires transcriptional and post-
transcriptionalstepssynchronized ina timelyand spatiallyregulated
[8].Eukaryotic ribosomesareconstituted offour different ribosomal
RNAs (rRNA) synthetized by RNA polymerase I (RNA pol I) and
RNA polymerase III (RNA pol III) that are assembled with eighty
different ribosomal proteins to form the 40S and 60S subunits. In
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7147mammals, the 40S subunit contains the 18S rRNA whereas the 60S
subunit contains the 28S, 5.8S and 5S rRNA. These rRNA are first
synthesized as precursor rRNA (pre-rRNA) molecules and undergo
extensive co- and post-transcriptional processing to produce
completely matured and functional rRNA. This processing includes
specific endo- and exo-nucleotidic cleavages to remove all the
transcribed sequences from the pre-rRNA that are not part of the
matured rRNA [9,10] as well as specific methylation and
pseudouridylation induced by ribonucleoproteins composed of
small nucleolar RNA (snoRNA) of two types (snoRNA C/D and
snoRNA H/ACA) associated with either fibrillarin for the
methylation or dyskerin for pseudouridylation [11–13]. The precise
function of these chemical modifications is not yet fully elucidated
but several recent data strongly suggest that they modulate
ribosomal assembly and translational capacity [14–19]. Experi-
mental data arehoweverstill missing to determine the regulations of
ribosome biogenesis and in particular those affecting the post
transcriptional steps during human carcinoma cell progression,
although recent studies indicate that these alterations might directly
contribute to tumorigenesis [18]
Oncogenesis and tumor progression in humans are supported
by the acquisition of activated oncogenes and/or the silencing of
tumor suppressor [20]. Recent data have associated the activity of
certain oncogenes and tumor suppressor with precise regulation of
ribosome processing [21–23]. For example, oncogenes such as c-
myc activate not only RNA pol II (involved in synthesis of mRNA
coding for ribosomal proteins) but also RNA pol I and III
(involved in rRNA synthesis) [23]. Moreover, the loss of functional
changes in the two major tumor suppressor proteins pRB and
TP53 activities induced a strong activation of ribosome biogenesis
in cancer cell [24]. More importantly, it has been shown that
oncogenic activity of c-myc could be suppressed by the direct
genetic control of ribosome biogenesis through a process that
involved the restoration of the IRES-dependent translational
ability of the cell that is otherwise deregulated by c-myc [25].
We have recently found that reduced content of ADP ribosylation
factor like 2 (Arl2) in breast tumor lines is associated with enhanced in
vitro and in vivo aggressivity (Beghin et al., submitted for publication).
Analysis of variant lines of the human breast adenocarcinoma lines
MCF7 and MDA-MB-231 showed that cells with reduced Arl2
content displayed reduced contact inhibition, increased clonogenic or
cluster formation as wellas a proliferative advantage over control cells
in an in vitro competition assay. These cells also caused larger tumors
in SCID mice, a phenotype which was mimicked by the in vivo
administration of siRNA directed against Arl2 or PP2A.
In the present study we have analyzed the rates and quality of
ribosomebiogenesisandrRNAprocessingaswellasthetranslational
capacityincellswithreducedArl2content[26,27].Weshowthatthe
acquisition of an aggressive phenotype in these cells is accompanied
by a strong activation of ribosome biogenesis supported by i)
activation ofthe rate of ribosome synthesis, ii) alteration ofthe rRNA
processing pathways and of their methylation pattern; iii) impair-
ment of the translational initiation ability via CAP or IRES-
dependent mechanisms and iv) an important alterations of
translational fidelity. These results show that the acquisition of an
aggressive tumor phenotype is associated with profound quantitative
and qualitative alterations in ribosomal biogenesis and function.
Results
Reduced Arl2 content is associated with profound
alterations in nucleolar morphology
Since the size, the morphology, the number and the ultra-
structural organisation of nucleoli are considered as potent
indicators of cellular nucleolar activity, the first part of our study
aimed to determine these characteristics in the more aggressive
MA- cells and the control MP cells. Nucleoli were visualized by
immunofluorescence experiments using antibodies directed against
two abundant nucleolar proteins, nucleolin and B23. Detection of
nucleolin and B23 signal is presented in figure 1A and 1B panel a
and b, the nucleolus is revealed by DAPI staining (panel c and d)
and the merged picture is presented in panel e and f. The
morphology and the number of nucleoli is very different in the
most aggressive cells compared with the MP control cells. It was
confirmed by signal detection of these staining by software
analysis. The circularity index (Fig. 1C) and the area (Fig. 1D)
of the nucleoli were then evaluated from 160 cells of each cell line
using the Image J software. These analyses showed that there was
no statistically significative differences between circularity index of
nucleoli from MP or MA- cells whereas the mean area of nucleoli
from MA- cells was 30% higher than that of nucleoli from MP
cells (p=0.01). Finally, quantification of the number of nucleoli
per cell (Fig. 1E) showed that the number of nucleoli varies from 1
up to 10 per cell in both cell lines but invasive mammary
carcinoma cells MA- exhibit a higher proportion of nuclei
containing more than 4 nucleoli as compared to the MP control
cell (p=0.01, Chi2 test). Confocal microscopy following DAPI
staining showed that approximately 40% of MA- cells displayed
very dense nucleoli as quantified into 200 cells using the ImageJ
software (p#0.01)(Fig. 1F). Electron microscopy showed that the
number of FC and DFC per nucleoli is higher in MA- cells
compared to MP cells, aproxymatively 4 FC per nucleolus in MA-
cells (p#0.01, t-test). A representative image is presented in
Fig. 1G. Altogether these results suggested that during human
breast cancer progression the nucleus undergo adaptative changes
supported by increased nucleolar activity.
Reduced Arl2 content is associated with increased
ribosome biogenesis
The rate of ribosome biogenesis was investigated in MP and
MA- cells by measuring the amount of [3H] uridine incorporated
during 1 h into i) the nuclear 45S pre-rRNA, representing the
initial unprocessed rRNA transcript synthesized by RNA pol I and
therefore reflecting the the overall rate of 45S pre-rRNA (Fig. 2A)
and ii) into the final mature rRNA associated with stable
cytoplasmic ribosomes representing an integrated view of all the
steps of ribosomal production (Fig. 2B).
For this, in a first step, following the 1 h labeling period with
[3H] uridine nuclear RNA was purified, resolved on an agarose
gel, transfered to a nitrocellulose membrane, the radioactivity was
measured with a phosphorImager (Figure 2A). This analysis
showed that the amount of radioactivity incorporated into 45S
pre-rRNA of MA- was increase of 20% than that incorporated
into the corresponding 45S pre-rRNA of MP (p=0.05). In
parallel, after the 1 h labelling period with [3H] uridine
cytoplasmic ribosomes were purified using dedicated methods
allowing ribosome purification with a high degree of purity,
subunits were separated with high salt concentration containing
buffers, tRNAs and mRNAs were eliminated using the amino acid
analogue puromycin and RNAse treatment and the radioactivity
was measured in equivalent amount of purified ribosomes in a
liquid scintillator counter (figure 2B). This analysis showed that the
amount of radioactivity incorporated in mature cytoplasmic rRNA
of MA- cells was 20% (p=0,0097) greater than that of the mature
cytoplasmic rRNA of MP cells. Altogether these data unambig-
uously showed that human breast cancer progression is associated
with an increase of 20% of the ribosome synthesis.
Ribosome Biogenesis and Cancer
PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7147Figure 1. The nucleolar structure is profoundly altered in aggressive human breast cancer cells. Immunofluorescent detection of the
nucleoli of the two cell lines using the nucleolin antibody (A) and the B23 antibody (B) on panels a and b. The nuclei are identified using DAPI staining
(blue signal) on panels c and d and images of merged signals are presented on panels e and f. (C) Analysis of the circularity of the nucleoli was
performed as described in material and methods using Image J software, and no significant differences were observed between the two cell lines.
The same image analysis was conducted for the calculation of the nucleolar area (D), demonstrating that nucleoli of MA- cells exhibit nucleoli 30%
larger than those of MP cells (p=0.01). The number of nucleoli per nucleus was quantified in MP and MA- cell (E). The graphic shows that MP cells
have an average of 4 nucleoli per cell whereas the average for MA- cells is about 6 nucleoli per cell (p=0.01). (F) Confocal microscopic analysis after
DAPI staining showed that 40% of MA- cells vs. MP cells present very dense nucleoli (p#0.01). Electron microscopic analysis of MA- and MP nucleoli is
presented in (G). The nucleoli of MA- cells exhibit significantly more fibrillar center as compared to those of MP cells (p#0.01). GC: granular
component, DFC: dense fibrillar component, FC: fibrillar center represented by a star. Scale bar is 1,2 mm.
doi:10.1371/journal.pone.0007147.g001
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an alternative pathway of rRNA processing
At present, it is generally admitted that there are two different
modes of human rRNA post-transcriptional processing [9]. These
modes of processing that are schematized in Fig. 3A, designated
pathway A and B, involve sequential cleavages of the initial pre-
45S rRNA to obtain the matures 18S, 5.8S and 28S. Therefore the
first step to analyse the modes of rRNA processing in MP and MA-
cells was to design a set of three probes – complementary to the
sequences of 18S, 5.8S and 28S - allowing the detection of all the
pre-rRNA yet described in human cells. As shown on Fig. 3B, we
were able to detect, in both MP and MA- cells, the different
subtypes of pre-rRNA that have been previously described in
HeLa cells (45S, 41S, 32S, 26S, 18SE, 12S) in addition to the
mature rRNA 5.8S and 28S. However, a supplementary 43S
intermediate present only in the invasive MA- cells and located
between the 45S and the 41S was reproducibly detected, very
strongly with the three probes. To verify the specificity of 43S
signal detect with the three preliminary probes, we have
performed a second northern blot experiment with two additional
probes specific of the 59ETS and 39ETS. In the case of the 43S
pre-rRNA, only the 59ETS does allow us to detect a signal,
whereas 39ETS does not recognize the pre-rRNA. We have
detected a signal in the MA- cell with the 59ETS probe but no
signal with the 39ETS. No signal was detected with either probe in
the control MP cells (data not show). This precursor could be
specific of a third rRNA pathway designated pathway C in Fig. 3A.
Our results show that in this model, cancer cells with enhanced
aggressivity acquire a supplementary pathway of pre-rRNA
processing.
Methylation pattern of rRNA is modified in cells with
reduced Arl2 content
We have then analyzed the cytoplasmic rRNA. Extensive
northern blot analyzes clearly showed that ribosomes contained
only the expected four rRNA species: 28S, 18S, 5.8S and 5S (data
not shown). However, because methylation of rRNA is one of its
chemical modifications that could play a critical role in its
function, the next step of our study was to analyse the methylation
pattern of a restricted part of the rRNA of MP and MA- cells. At
present the method of reference for this kind of analysis [16,28]
proceeds following two main steps: i) a reverse transcription (RT)
using a radioactive oligonucleotide generally located 50 bases
dowstream to the methylation site to be analyzed and performed
either with a high nucleotide concentration (1 mM) or with a low
nucleotide concentration (10 mM); ii) analysis of the resulting
radioactive complementary DNA (cDNA) by separation within
denaturing polyacrylamide gels and detection by autoradiography
or PhosphorImager. The principle of the method is: i) that the
eventual methyl group located at the 29 position of the ribose stops
Figure 2. Polymerase I activity and ribosome biogenesis are activated in aggressive human breast cancer cells. A: RNA polymerase I
activity. The activity of the RNA pol I was investigated in MP and MA- cells by counting the radioactivity directly incorporated into the 45S pre-rRNA .
Quantification of the amount of [
3H]-uridine incorporated into pre-rRNA 45S show a 20% increase in MA- cells (p=0.05, n=3). The amount of
radioactivity is expressed as percentage with the result obtained for MP cells taken as the reference and is presented as mean +2 S. E. M (n=3). B:
Rate of cytoplasmic ribosome biogenesis. The rate of ribosome biogenesis was evaluated by counting the radioactivity incorporated into purified
mature cytoplasmic ribosome. Quantification of the amount of [
3H]-uridine incorporated into cytoplasmic ribosome (determined as above)
demonstrate a 20% increase in cytoplasmic ribosome biogenesis in MA- cells as compared to control MP cell (n=3).
doi:10.1371/journal.pone.0007147.g002
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PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e7147Figure 3. A new rRNA processing pathway is detected in aggressive human breast cancer cells. A: rRNA processing pathways. Simplified
diagram of the two major pre-RNA processing pathway in HeLa cells (pathways A and B) and a third chemically-induced pathway (pathway C). Thin
lines represent the sequences that are eliminated during the processing (59ETS, ITS1, ITS2, 39ETS) to provide mature rRNA (18S, 5.8S and 28S)
represented by thick black boxes. Names of the intermediary species refer to the current nomenclature. The positions of the main cleavage sites are
indicated by arrowheads and refer to conventional numbering. B: Northern blot analyses. Nuclear RNA (3 mg) was analysed by northern blot using
specific probes for the 18S, 5.8S and 28S sequences. Results show that all the pre-rRNA corresponding to the pathways A and B of rRNA maturation
exist in MP and MA- cells. A third pathway of rRNA maturation characterized by the presence of the 43S pre-rRNA (red arrow) is evidenced only in the
aggressive MA- cell line. This intermediary is specific of the C pathway.
doi:10.1371/journal.pone.0007147.g003
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nucleotide is used whereas cDNA synthesis is not altered when
high concentrations of dNTP are used and ii) that separation and
relative quantification of radioactive cDNA produced at low and
high dNTP concentration allows to determine the presence or the
absence of the methyl group. This method is very specific and has
been extensively validated. However, it is time consuming,
requires the manipulation of radioactive compounds, suffers from
a lack of sensitivity, does not allow simultaneous analysis nor more
importantly quantification and does not allow us to determine the
percentage of multiple rRNA molecules that are methylated at a
given position. Therefore to circumvent these limitations, we have
modified the existing method. The synopsis of the modified
method is presented in Fig. 4A. The first step is very similar to the
classical method except that the oligonuceotides used are non-
radioactive and that the efficiency of the RT is precisely controlled
(see Materials and Methods). The second step is totally different to
that of the classical method because the cDNA resulting from both
RT (performed with low and high dNTP concentration) are
precisely quantified using a qPCR technology described in great
details elsewhere[29,30]. The number of cDNA copies obtained
after RT at high concentration is divided by the number of cDNA
copies obtained after RT at low concentration. This methylation
ratio (MR) gives an evaluation of the percentage of rRNA that is
methylated at a given position Using this modified method we
have compared the MR between MP and MA- cells from 11
different methylation sites distributed throughout the 5.8S, the 18S
and the 28S (figure 4B). For this, the three cytoplasmic rRNA from
both cell lines were separated onto an agarose gel, extracted from
the gel and submitted to methylation analysis according to the
method described in Fig. 4. This analysis showed that the MR of
the 28S from MA- were always higher than those of MP cells
whatever the sites analyzed suggesting that MA- 28S rRNA and
18S rRNA is more methylated than MP 28S rRNA. Conversely
MR of 5.8S of MP and MA- rRNA are very similar suggesting that
the level of methylation of these rRNA positions is equivalent in
both cell lines. The ratio between the MR of the two cell line are
presented in figure 4C, and we can show that this ratio is between
1.4 and 6 fold higher for the most aggressive cell. We have then
performed a validation of our novel detection method of rRNA
methylation. For three different sites (position 1489 in the 18S
rRNA and positions 1856 and 4436 in the 28S rRNA), we have
analyzed the methylation ratio according to the standard method.
This analysis showed that the methylation ratio measured with
either the standard method or the new RT-qPCR method were
very similar. Respective fold changes of the rate of methylation
between MA- and MP cells for the three sites analyzed were 1.8,
1.6 and 1.1 with the RT-qPCR method and 1.35, 1.85 and 1.06
with the standard method.These results confirmed that the rate of
rRNA methylation of at least some sites is higher in the most
aggressive cells.
Reduced Arl2 content is not associated with the protein
composition of cytoplasmic ribosomes
To determine more extensively the structure of the ribosome,
we have analyzed the composition of the ribosomal protein of the
cytoplasmic ribosome of each cell line. After purification of the
cytoplamic ribosomes, the ribosomal proteins were extracted and
separated by 1D SDS-PAGE (figure 5A). As expected we detect
the 80 ribosomal proteins in the two cell lines and the composition
seems equivalent in the most aggressive and in the control cells.
However, mono-dimensional separation of protein does not
permit a fine analysis of the protein composition of the ribosome.
We have in a next time performed a two dimensional analysis of
ribosomal proteins in a dedicated 2D electrophoresis system that
allows to visualize the 80 proteins and to characterize the specific
post translational modification of the proteins. Gels are presented
in figure 5B. Annotation of each protein is performed with the
previous analysis in HeLa cells. All the proteins are detected in the
right place and the protein composition of ribosome are similar in
the two cell lines. To verify the abundance of each protein, we
have performed a bio-informatic analysis using ImageMaster
software with 5 gels of each cell line. The signal obtained for each
protein are indentical in MP ad MA- cells (figure S1).
Our results show that during human breast cancer progression,
invasive cancer cells displays the same composition of ribosomal
protein in cytoplasmic ribosome.
Reduced Arl2 content is associated with dysregulation of
translational efficiency
It was recently describe that alteration on ribosome biogenesis
is associated with dysregulation of translational efficiency. In
particular, ribosome alterations are associated with modification of
initiation of translation by IRES element and strong defect in
translation fidelity.
We first analyzed the rate of global protein synthesis. For this,
proteins were labelled for 1h by incubation of the cells in a
medium containing a mixture of [35S]-methionine and [35S]-
cysteine Cells were solubilized and equal amounts of total proteins
were separated by SDS-PAGE. Proteins were stained by
Coomassie brillant blue, the gels were dried and the radioactivity
incorporated in the separated proteins was evaluated using the
ImageQuant TL software after PhosphoImager scanning
(Figure 6A). No significant difference was observed between
MA- and MP suggesting that the global translational activity is
equivalent in both cell lines.
We then determined whether the mode of translational
initiation, cap- or IRES-dependant was equivalent or different in
these cells. For this we used a bi-cistronic vector strategy in which
translation of the first cistron is mediated by a cap-dependent
scanning mechanism and the second by an IRES-dependant
mechanism. These vectors were transfected into MP and MA- cells
and translation efficiency of the two coding sequences was
evaluated by measuring the two luciferase enzyme activities
(Figure 6B). The results were normalized using the Rluc activities.
This clearly demonstrated that aggressive MA- cells displayed a
significantly lower IRES-dependent translational activity (4-fold
less, p,0,05) than that of MP cells whatever the origin of the
IRES, either human (p53, IGF-IR, c-myc, FGF1, FGF2, VEGFA
and VEGFB) or viral (EMCV). Moreover, usage of an hairpin
containing vector (pHBic-943) clearly showed the specificity of the
IRES-dependant initiation and allowed to demonstrate that
translation of the second cistron was not performed via a
terminaison re-initiation mechanisms (Fig. 6B).
We have also analysed two different aspects of the fidelity of
translation: nonsense suppression and aa-tRNA selection. To
evaluate nonsense suppression we produced a pGL3 firefly
luciferase vector containing a premature stop codon. As shown
in Fig. 6C, ribosomes of both cell lines displayed the ability to pass
through the premature stop codon although this dysfunctional
property was 30% higher in the most aggressive cells MA- cells
than the control cells MP. To evaluate the aa-tRNA selection we
produced a vector in witch the AGA codon was transformed into
the near-cognate AGC leucine codon. The R218 residue is a
critical amino acid for Fluc activity and this mutation induces the
synthesis of a protein with a strongly reduced luciferase activity
[14] . Therefore, measuring the level of Fluc activity from this
R218A vector allowed us to evaluate the rate of amino acid
Ribosome Biogenesis and Cancer
PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e7147Figure 4. The specificity of the methylation pattern of rRNA is altered in aggressive human breast cancer cells. A: schematic
representation of the RT-PCR mapping method used to analyse the methylation pattern of rRNA. The first RT step is identical to the conventional
method of rRNA methylations analysis. In the second step however, some adaptations were introduced, first by using a non-radiolabelled probe and
next byperforminga qPCR ofthetwoRTproducts. B: Methylationratio ofelevensites distributedthroughoutthethreerRNA. Thepositionline indicates
thenumberofthenucleotide thatis analysed. White bars indicatethemethylationratio (MR) ofMP cellsandblackbars indicate the MR of MA- cells.One
site was analysed for the 5.8S, four sites for the 18S and six sites for the 28S according to the method described in the experimental procedure. The MR
for the sites analysed on the 5.8S are equivalent in the two cell lines whereas the MR of the sites on the 28S and 18S are higher in MA- cells as compared
to control MP cells. Significant differences are indicated by the stars. C: Fold change in the MR between MA- and control MP cells. The fold change
represents the calculationoftheratio betweentheMRofMA- cells andtheMR ofMPcells.As indicated inthis table,thefoldchangesintheMR between
MA-andMPcellsareusuallybetween1.5 and2 fortheselected sites onthe28SrRNA whereasthefold changesareabout1 forselectedsites onthe5.8S
and 18S rRNA. Only one site (1713) on the 18S rRNA exhibit a fold change in the MR between MA- and MP cells of 6.
doi:10.1371/journal.pone.0007147.g004
Ribosome Biogenesis and Cancer
PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7147Figure 5. The protein composition of the ribosome is not modified in aggressive human breast cancer cells. The composition of the
ribosome from MA- and MP cells was analysed on purified fractions of cytoplasmic ribosome obtained as described in material and methods.
Ribosomal proteins were first resolved by 1D SDS-PAGE (panel A), and every ribosomal protein could be clearly detected in the two cell lines, with no
apparent quantitative alteration. To increase the resolution of the analysis, ribosomal proteins were next resolved by using a specific 2D-gel system
(B) and each protein spot was quantified by image analysis using the ImageMaster software. Again, no difference was observed in the composition
of ribosomal proteins between the MA- and MP cell lines.
doi:10.1371/journal.pone.0007147.g005
Ribosome Biogenesis and Cancer
PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e7147Figure 6. The translational capacity of the ribosome is modified in aggressive human breast cancer cells. A: Rate of global protein
synthesis. Cells were incubated in a mixture of
35S labelled-cystein and methionine. Total proteins (15 mg) were separated by monodimensional
electrophpresis and transferred to a nitrocellulose membrane. The radioactivity incorporated into proteins was measured using a PhosphorImager
(Typhoon Trio, GE). The results represent three independent experiments and the radioactive counting was done in triplicate. In each experimental
condition the data obtained (Mean +/2 S.D) are expressed as the percentage of those obtained in the control MP cell line. The results show no
significant differences in the global rate of protein synthesis between the MA- and the MP cell lines. B: Determination of the translation initiation
through IRES. Both Firefly and Renilla Luciferase were transfected into the cells and activities were measured as described under ‘‘materials and
methods.’’ The result for the Firefly luciferase was normalized by the data for Renilla luciferase activity. In each condition of transfection, the data
obtained (Mean +/2 S.D, n=5) are expressed as the percentage of those obtained in the control MP cell line. The results clearly indicate that
translation initiation through IRES is impaired in MA- cells as compared to MP cells. C: Analysis of translational fidelity in MA- and MP cells. Both cell
lines were transfected either with the pGL3m1 vector (stop mutant) or the pGL3 wild type vector. Luciferase activities of the mutant vector and of the
pGL3 vector were assessed by co-transfecting the pRL vector. The results of the Firefly luciferase activity of the mutant were normalized by the Firefly
luciferase activity of the wild type vector. The data (Mean +/2 S.D, n=5) are expressed as the percentage of those obtained in the control MP cell
line. The results indicate that firefly luciferase activity of the mutant vector is highly expressed in MA- cells as compared to MP cells. D: Analysis of
translational fidelity in MA- and MP cells using another mutant vector (pGL3m2). Cells were transfected with either the pGL3m2 vector or the pGL3
wild type vector. Luciferase activities of the mutant vector and of the pGL3 vector were assessed by co-transfecting the pRL vector The results of the
Firefly luciferase activity of the mutant were normalized by the Firefly luciferase activity of the wild type vector. The data (Mean +/2 S.D, n=5) are
expressed as the percentage of those obtained in the control MP cell line. Once again, the results indicate that firefly luciferase activity of the mutant
vector is highly expressed in MA- cells as compared to MP cells, clearly demonstrating a strong defect in translational fidelity of MA- cells.
doi:10.1371/journal.pone.0007147.g006
Ribosome Biogenesis and Cancer
PLoS ONE | www.plosone.org 9 September 2009 | Volume 4 | Issue 9 | e7147misincorporation at this position – resulting from altered aa-tRNA
selection - since this level reflects the amount of ‘‘reverted
proteins’’ in which an R residue was incorporated instead of the
expected A residue (Fig. 6C). As expected the level of Fluc activity
was low in both cell lines. However, the Fluc activity was 40%
higher in MA- cells. This result show that ribosome of aggressive
cell lines are deficiency the codon- anticodon recognition.
Our results show that in this model of enhanced tumor
aggressivity, the translational capacity of the ribosome of invasive
cancer cells is strongly impaired. IRES-initiated translation was
less efficient and fidelity of translation was reduced in cells with
increased aggressivity.
Discussion
It is now clearly established that control of ribosome biogenesis
is profoundly altered by several oncogenes and/or tumor
suppressor [20]. In particular, many studies have demonstrated
that over expression of oncogenes or silencing of tumor suppressor
induce an increase of RNA pol I activity [21,23,31]. The data
presented in this study show that these alterations are not restricted
: i) to only the transcriptional step of ribosomal biogenesis and ii) to
the early steps of tumor formation but that important modifica-
tions of this fundamental biological process also take place at later
stages of tumor evolution, i.e. during the acquisition of the
aggressive tumor phenotype. Indeed we demonstrate that breast
tumor cells exhibiting an exacerbated aggressive phenotype (MA-)
both in vitro and in vivo display an increase of their rate of ribosome
biogenesis accompanied by a modification of the post-transcrip-
tional rRNA processing together with a modification of their
translational control ability.
The rate of ribosome biogenesis was evaluated directly by
measuring the level of incorporation of
3H-uridine within
cytoplasmic ribosomes of MP and MA- cells. This unambiguously
showed that the rate of ribosome synthesis is higher in the most
aggressive cell line, MA-. This result was indeed a confirmation of
the observation that the mean size of MA- nucleoli was about 30%
higher than that of nucleoli from MP cells and that a significant
percentage of MA- cells display more nucleoli per cell. The higher
rate of ribosome biogenesis measured in MA- cells was also
reflected at the ultra-structural functional organisation of the
nucleoli of MA- cells (analyzed by electron microscopy) in which
the number of FC and DFC per nucleoli is higher in MA- cells
compare to MP cells. Altogether these results demonstrated for the
first time that ribosome biogenesis could be over-activated not only
during the early steps of tumor progression but also in correlation
with acquisition of the aggressive phenotype. Interestingly this also
contributes new experimental data supporting the fact that
AgNOR could be considered as a ‘‘gold standard’’ pathological
feature for clinicians [32] since it could reflect not only the
transformed state of a cell but also its level of aggressivity.
Because ribosome biogenesis is a complex multistep process and
because the post-transcriptional modifications of the rRNA are
crucial for ribosomal functions, the next step of the study was to
determine whether these steps of ribosome biogenesis were also
modified in the most aggressive cells (MA-) compared to the less
aggressive cells (MP). For this we have first demonstrated that the
MP cells exhibit the same nuclear pre-rRNA intermediates than
those already characterized in another transformed human cell line,
the HeLa cell line suggesting that processing of rRNA is very similar
in these two cell lines. This processing occurs through two different
modes representing different kinetics and different orders of pre-
rRNA processing that are conventionally referred to as pathways A
and B [9,10]. Unexpectidely, in MA- cells, a supplementary
intermediate was observed demonstrating that a third mode of pre-
rRNA processing occurs in this cell line. The existence of a third
pre-rRNA processing pathway could have two different potential
consequences on the global control of ribosome biogenesis. First, it
can be postulated that the post-transcriptional rRNA processing is
more efficient in the more aggressive cells (three pathways)
compared to the control cells (two pathways) and that this activation
of post-transcriptional processing is required, in addition to
transcriptional activation, to provide the required amount of
cytoplasmic ribosomes. Second, since the post-transcriptional
chemical modifications of rRNA occurs during the early steps of
processing and since the ‘‘abnormal’’ appearance of 43S pre-rRNA
involves a deregulation of the early steps of processing, it can be
postulated that the chemical modification profiles of the aggressive
cells are different from that of the control cells.
Therefore, because these specific chemical modifications that
rRNA undergo during their processing are absolutely crucial for
ribosomal function [15,17–19,33] the next step of our study was to
evaluate the ratio of methylation of rRNA. At present, several
methods are available to determine the presence of methyl group
in rRNA. First, radiolabelling of methyl groups by [
3H]methyl-
methionine incorporation in cell culture. This technique gives only
a global vision of the rRNA methylation and does not permit a
single point methylation analysis. Moreover, the incorporation of
[
3H]methyl group is dependent of the methylation rate but also of
the rate of rRNA synthesis by RNA polymerase I. Second, single
methylation point analysis by reverse transcription with radioac-
tive oligonucleotide.
The initial step of the existing method corresponds to two
reverse transcription (RT) reactions performed with a specific
radioactive oligonucleotide for a target site at high or at low
concentration of dNTP. At high concentration, the RT reaction is
not blocked by the methyl group whereas at low concentration, the
reaction is blocked by the methyl group producing radioactive
cDNA of different sizes. The amount of cDNA was then evaluated
after electrophoresis and autoradiography. The major limitation of
this method is that it does not allow to determine the percentage of
rRNA molecule that exhibit a methyl group at a given position.
Therefore to circumvent the limitations describe above, we have
simply replaced the radioactive detection part of the available
method by a well standardized qPCR method (see Results and
Experimental procedures sections for methodology). This method
allowed us to evaluate the percentage of rRNA molecules
methylated at a given position and to determine the methylation
ratio (MR) for each selected site. For all the reasons described
above we have performed the methylation ratio analysis for 11
sites in the two cell lines distributed in the three main rRNA (5.8S,
18S and 28S) [11] .
The MR for the sites present in the 5.8S of MP and MA- rRNA
are very similar suggesting that the level of methylation of these
rRNA positions is equivalent in both cell lines. In contrast, the MR
of the six sites present in the 28S rRNA and in the 18S rRNA is
more elevated in the aggressive MA- cell line than in the control
MP cells. As an example, the methylation at position 1858 is two
fold higher in the aggressive cells and the methylation at position
1803 is six fold higher. Therefore, the fact that the methylation
pattern of mainly the 28S and 18S rRNA seems to be altered
suggests that a modulation of ribosomal function could be
performed via this mechanism since the peptide bound formation
and, to a lesser extent, the tRNA selection activities of the
ribosomes are provided by the 28S rRNA and the methylation
sites of this rRNA are heavily concentrated in its active sites.
However, at this stage the methylation rRNA analysis encompass
only 10 % of the total rRNA methylation, therefore we can not
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according to the cell line. The exact function of the methyl groups
in the rRNA is not yet clearly understood although it is now well
demonstrated that collectively they can control, at least in part, the
translational activity of the ribosomes [15,16,33]. In the future
development of high throughput methods to analyse the level of
RNA methylation would be extremely useful.
It has recently been demonstrated that incorrect methylation of
rRNA is associated with impaired capacity to initiate translation
through IRES and also with a strong defect in translational fidelity
[25]. In our study we have demonstrated that the capacity to
initiate cap-independent translation by eight different IRES (viral
IRES of EMCV and several cellular IRES) is lower in the
aggressive MA- cell line and that the ribosome of these cells exhibit
a strong deficiency in reading the mRNA. These results suggest
that alterations of rRNA maturation observed in aggressive cells
have a direct effect on the translational capacity of the ribosome.
The modulation of IRES-translation initiation plays a central role
in tumorigenesis since IRES elements have been found in several
cellular mRNAs including those of different growth factors (for
review [34]), proto-oncogenes such as c-myc [35] transcription
factors [36] , and proteins involved in cell cycle progression
[37,38] or apoptosis [39].
Finally, the modification of ribosome biogenesis observed in
aggressive MA- cells with reduced Arl2 levels can be explained by
the role of p53, since it has been shown that reducing the level of
Arl2, suppresses p53 expression [26,27]and p53 inactivation is
associated with up-regulation of RNA polymerase I activity. It now
remains to determine whether p53 could modify the post-
transcriptional steps of ribosome biogenesis, in particular the level
of rRNA methylation
Altogether our results show that breast cancer cells with enhanced
aggressivity display profound alterations in ribosome biogenesis
resulting in the modification of translational initiation ability of the
ribosomes. Further investigations will aim to determine how these
alterations, and most notably reduced translational fidelity of these
altered ribosomes, are involved in increased tumor aggressivity.
Materials and Methods
Cell culture
MP and MA- cell lines were obtained with MCF-7 cells stably
transfected with empty pcDNA3 (MP cells) or pcDNA3 containing
antisense Arl2 (MA- cells) [27]. The two cell lines were grown in
DMEM containing L-glutamine, penicillin (200 IU/ml), strepto-
mycin (200 mg/ml), and foetal bovine serum (10%) at 37uC in the
presence of 5% CO2.
Plasmid construction
Bicistronic plasmid construction and dual luciferase assays have
been described [40]. Briefly, the plasmids used were constructed
by cloning the RLuc gene as the first cistron under the control of
the cytomegalovirus promotor (CAP dependent translation) and
the FLuc gene as the second cistron under the influence of IRES of
the IGF-IR mRNA (pBiC-943), IRES of p53 or of that coding for
the encephalomyocarditis virus (EMCV) IRES (pBiCV). The
pHBIC-943 vector is identical to the pBIC-943 vector except for
the introduction of a hairpin sequence before the RLuc gene.
Vector containing IRES of c-myc, FGF1, FGF2, VEGFA and
VEGFB are provided by the group of Anne Catherine Prats [41] .
pGL3 mutant stop vector (pGL3m1) corresponds to the Firefly
luciferase of the pGL3 vector with a premature stop codon (UAG)
at the position 333 of the coding sequence. pGL3 misincorpora-
tion test reporters (pGL3m2) was created by mutating the firefly
luciferase catalytic residue R218 from the wild-type AGA codon to
the near-cognate AGC leucine codon of the pGL3 vector. Mutant
sequences were obtained by site-directed mutagenesis using PCR
from 30 ng of pGL3 vector (Promega), pfu DNA polymerase
(Stratagene) and the following primers (Eurogentec):
333-59-GGAAGATGGAACCGCTGGATAGCAACTGCATA-
AGG-39
333-59-CCTTATGCAGTTGCTATCCAGCGGTTCCATCT-
TCC-39.
R218-59-CTAAGGAAGTCGGGGUAGCGGTTGCCAAGA-
GGTTC-39
R218-59-GAACCTCTTGGCAACCGCACCCCGACTTCCT-
TAG-39
In order to standardize the pGL3 mutants and the pGL3 wild
type expression, we performed a co-transfection with the pRL
vector coding for renilla luciferase Transfection were made at the
ratio J–L for mutant vector and pRL respectively. These
plasmids were transfected into MP, and MA- cells using
lipofectamine 2000 (Invitrogen) according to the manufacturer
information and tested with dual luciferase (Promega) ..
Fluorescence and electron microscopy
Cells were processed for electron microscopy as previously
described [22]. For immunofluorescence analysis, cells were grown
on glass coverslips, fixed with 4 % of paraformaldehyde in PBS
before permeabilization with 1 % Triton X-100 in Phosphate
Buffered Saline (PBS). B23 and nucleolin proteins were localized
using respectively mouse monoclonal antibodies B0556 (Sigma)
and rabbit polyclonal antibody (P. Bouvet, ENS Lyon) and a
FluoProbes 546 anti-mouse secondary antibody (Interchim).
Coverslips were mounted using the Fluoromount G medium.
DNA staining was performed using di-aminido-phenyl-indol
(DAPI) (Roche, Manheim, Germany) according to manufacturer
instructions. Staining was visualized at room temperature by
Fluorescent microscopy. Images were captured using an AxioCam
HR camera, acquired with the LSM software (Zeiss). Signal
quantification was performed with Image J software (USA).
RT-qPCR analysis of the methylation pattern of rRNA
Methylation of rRNA was analyzed by RT-qPCR. A total of 11
methylation sites was selected for 5.8S, 18S and 28S. Reverse
transcription of rRNA into cDNA was realized using 100 ng of
purified 5.8S, 18S and 28S rRNA, extracted from MA- and MP
cells, in the presence of 200 units of M-MLV reverse transcriptase,
RNase H minus (Promega M3683), 40 units of RNasin Ribonu-
clease inhibitor (Promega N2515), 1 mM of each reverse primer
targeting a sequence upstream to a specific methylation site, and
either 10 mM or 1 mM dNTPs. In each reaction tube, 7.5610
8
copies of a synthetic polyA RNA (SmRNA), used as an external
standard, were added to calibrate the efficiency of reverse
transcription (Morales and Bezin, patent WO2004.092414), as
previously described (Navarro et al., 2008). Reverse transcription
has been performed at 42uC for 90 min, and then stopped by an
incubation at 70uC during 15 min. Quantitative amplification of
the targeted cDNAs was performed by PCR using a Lightcycler
1.2 (Roche Diagnostics), and the QuantiTect SYBR Green PCR
kit (Qiagen). Sequences of the primers used for PCR are provided
(table S1 )
Rate of protein synthesis
Cells were incubated one hour in methionine-free cysteine-free
DMEM (Gibco) supplemented with 10% inactivated and dialyzed
FCS and a mix of [35S] methionine and [35S] cysteine at final
concentrations of 75 mCi/ml (GE healthcare). After 1 h of
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with ice cold PBS. Cells were disrupted in Laemmli buffer and an
aliquot of each sample containing an equal amount of proteins was
separated in a 12.5% polyacrylamide gel. Gels were stained with
Coomassie blue, vacuum dried and analyzed by phosphoImager
(typhoon trio, GE Healthcare).
Rate of polymerase I activity and of ribosome synthesis
Cells were incubated one hour in DMEM supplemented with
10% inactivated FCS and [5,6–3H] uridine at a final concentra-
tion of 15 mCi/ml (GE healthcare). At the end of labelling time,
cells were washed three times with ice cold PBS containing 10–4M
of uridine. For RNA polymerase I activity, radioactive nuclear
RNAs were separated in formaldehyde agarose gels, transferred to
nitrocellulose membranes. Radioactivity of the 45S pre-rRNA was
measured after exposure of the membranes using a Phosphor-
Imager system (Typhoon and ImageQuant TL, Amersham). To
determine the rate of ribosome synthesis a post mitochondrial
fraction was prepared as previously described [42]. This
supernatant was treated for 15 min at 0uC followed by 10 min
at 37uC with puromycin at a final concentration of 10–4M and
then adjusted to 100 mM CaCl2 before treatment with 100 Units
per ml of micrococcal nuclease (Boerhinger) for 15 min at 20uC.
Ribosomes were purified by centrifugation through a 1M sucrose
cushion containing 0,5M KCl and quantified. An amount of
ribosomes corresponding to one A260 unit was mixed with 10 ml
scintillator (Beckman) and the amount of radioactivity was
measured in a liquid scintillation counters (Perkin).
2D analysis of ribosomal proteins
Ribosomes and ribosomal proteins were purified as previously
described in detail [43–45]. After purification proteins were
alkylated with iodoacetamide and separated by two dimensional
2D-PAGE as described in details elsewhere [46]. In brief, 2.5
OD260 units of each ribosomal protein preparation were
separated in the first dimension in a 4% (w/v) polyacrylamide
gel containing 8M urea at pH 8.6. The second dimension
separation was performed in a 12.5% polyacrylamide gel
containing 6M urea at pH 6.75 in the presence of SDS. Gels
were stained with Coomassie brillant blue R250. The intensity of
each spot was determined with the software Image Master (GE
Healthcare).
Northern blot analysis
Nuclear fraction was obtained after cell disruption 5 min at 0uC
using buffer RLN (50 mM Tris-HCl pH 8, 140 mM NaCl, 1,5 mM
MgCl2et 0,5% (v/v) Nonidet P-40). Nuclear RNA was purified using
the RNeasy kit (Qiagen) and quantified with a nanodrop spectro-
photometer (Thermo-Scientific). Nuclear RNA were separated in
formaldehyde agarose gels, transferred to nitrocellulose membranes.
Sequences of the oligonucleotide probes (Invitrogen) used for
northern blot analyses are the following: 18S- 59-ATCGGCCC-
GAGGTTATCTAGAGTCACCAAA-39,2 8 S -5 9-CCTCTTCG-
GGGGACGCGCGCGTGGCCCCGA-39 and 5.8S- 59-TCAGA-
CAGGCGTAGCCCCGGGAGGAACCCG-39. For labeling, 50
pmoles of each probe were incubated with 50 pmoles of [?-32P] ATP
and T4 polynucleotide kinase (Promega) during 30 min at
37uC.Northern blot hybridization was performed as described in
[47] and signal detection was performed by PhosphorImager
(Typhoon, GE Healthcare) scanning.
Supporting Information
Figure S1 Signal quantification of ribosomal proteins. Five gels
of ribosomal protein stained with Coomassie blue of the two cell
lines were analyzes using the ImageMaster software. Spot were
detected and the intensity of each spot were quantified.
Annotation of spot were performed using ribosome cartography
made in HeLa cells. The intensity of signal corresponding of the
proteins of the large subunit are presented in panel A and the
intensity of ribosomal protein of the small subunit are presented in
panel B. For all the ribosomal protein, the signal intensity of each
ribosomal proteins is equivalent in the two cell lines.
Found at: doi:10.1371/journal.pone.0007147.s001 (0.10 MB TIF)
Table S1 Oliginucleotides for detection of methylation by RT-
qPCR and amplification product size.
Found at: doi:10.1371/journal.pone.0007147.s002 (0.04 MB
DOC)
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